Table 3. Comparison of Approvals by Source of Sponsorship.
| 1975–1999 | 2000–2009 | |
| Number of Individual Products Approved | 46 | 26 |
| Number of Products Sponsored by PPP (% of Total) | 7 (15%) | 12 (46%) |
| Number Sponsored by Private Industry (%) | 38 (83%) | 12 (46%) |
| Number Sponsored by Other/Unknown (%) | 1 (2%) | 2 (8%) |
Sources: PharmaProjects, IMS R&D Focus, http://www.accessdata.fda.gov/Scripts/cder/DrugsatFDA, http://eudrapharm.eu/eudrapharm/searchbykeyword.do, http://www.cbg-meb.nl/CBG/en/human-medicines/actueel, http://www.pharmacyboardkenya.org/index.php?id=13&dpgndg1=42&an=, http://www.who.int/medicines/publications/08_ENGLISH_indexFINAL_EML15.pdf, http://www.cdsco.nic.in/, http://www.afssaps.fr/, http://www.mhra.gov.uk/index.htm, http://www.bmg.bund.de.